Understanding PCOS
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting 6–15% of this population depending on diagnostic criteria used. It is characterized by:
- Androgen excess: Elevated testosterone or DHEAS; clinical signs include acne, hirsutism, male-pattern hair loss
- Ovulatory dysfunction: Irregular or absent periods, anovulation
- Polycystic ovarian morphology: On ultrasound (though this alone doesn't establish diagnosis)
At its core, insulin resistance plays a central role in most PCOS presentations. Hyperinsulinemia drives excess androgen production from the ovaries and impairs SHBG production (which would otherwise bind and reduce free testosterone). This is why insulin-sensitizing interventions are among the most studied treatments.
PCOS requires proper diagnosis and medical management. This article is educational and discusses supplements being studied as adjuncts to medical care — not as replacement therapies. Individuals with PCOS should work with a qualified healthcare provider.
1. Inositol: The Most Evidence-Backed PCOS Supplement
Inositol is a sugar alcohol involved in insulin signaling, FSH receptor sensitivity, and other hormonal pathways. Two forms are primarily studied in PCOS:
- Myo-inositol (MI): More abundant form; involved in insulin signaling and FSH receptor function
- D-chiro-inositol (DCI): Involved in insulin action in peripheral tissues; converted from myo-inositol via the enzyme epimerase
Women with PCOS show both lower overall inositol levels and impaired conversion of MI to DCI in insulin-sensitive tissues.
The Research
Menstrual cycle regularity: A 2007 double-blind RCT (Fertility and Sterility, Nestler et al., n=44 PCOS women) found myo-inositol (4g/day for 14 weeks) restored ovulation in 62% of participants vs. 27% in the placebo group — a significant improvement.
A 2012 meta-analysis (European Review for Medical and Pharmacological Sciences, Raffone et al.) analyzed 4 RCTs of inositol in PCOS and found significant improvements in menstrual cycle regularity, ovulation rate, and insulin sensitivity.
Androgen levels: Multiple trials found inositol reduces total and free testosterone and reduces DHEAS in PCOS women, likely through improved insulin sensitivity reducing ovarian androgen production.
Metabolic parameters: A 2009 double-blind study (European Journal of Endocrinology, Papaleo et al.) found myo-inositol reduced HOMA-IR (insulin resistance index), improved lipid profiles, and reduced BMI in PCOS women over 6 months.
MI:DCI Ratio Controversy
The optimal myo-inositol to D-chiro-inositol ratio has been studied. A 2013 RCT comparing myo-inositol alone, DCI alone, and a 40:1 MI:DCI combination found the combination produced better outcomes for hormonal parameters and fertility — with the 40:1 ratio reflecting physiological tissue ratios. Many current products use this ratio.
Typical dose: 4g/day of myo-inositol, or 1.1g MI + 27.6mg DCI (40:1 ratio), sometimes with 400mcg folate
2. Berberine: Insulin Sensitizer with PCOS Evidence
As covered in detail in the fasting mimetics article, berberine is an AMPK activator with evidence comparable to metformin for improving insulin sensitivity.
PCOS-Specific Research
A landmark 2012 randomized trial (Clinical Endocrinology, Tang et al., n=89 PCOS women) compared berberine (500mg three times daily), metformin (500mg three times daily), and a combination in PCOS.
Results after 3 months:
- Both berberine and metformin significantly reduced testosterone, LH/FSH ratio, and improved menstrual cycle frequency
- Berberine was superior to metformin for BMI and waist circumference reduction
- Combination showed advantages for lipid profiles
A 2015 meta-analysis (Evidence-Based Complementary and Alternative Medicine) of 5 RCTs confirmed berberine significantly improved hormonal profiles, ovulation rates, and metabolic parameters in PCOS.
Typical dose: 500mg two to three times daily with meals (doses used in PCOS trials)
Comparison with Metformin
Berberine and metformin have overlapping mechanisms (both activate AMPK, both improve insulin sensitivity, both are PCOS-relevant). Metformin is the pharmaceutical standard of care for insulin-resistant PCOS. Berberine represents an accessible over-the-counter option with a comparable evidence base for PCOS-specific outcomes — though it should not be considered a pharmaceutical substitute without medical guidance.
3. NAC (N-Acetylcysteine): Antioxidant and Insulin Sensitizer
N-acetylcysteine is a precursor to glutathione (the body's primary endogenous antioxidant) and also has direct antioxidant and insulin-sensitizing properties.
PCOS is associated with elevated oxidative stress — higher reactive oxygen species and lower antioxidant capacity — which may contribute to the metabolic dysfunction and ovarian inflammation seen in the condition.
PCOS Research
Metabolic parameters: A 2006 double-blind RCT (Fertility and Sterility, Thakker et al.) compared NAC (1.8g/day for 3 months) with placebo in PCOS women and found significant improvements in insulin sensitivity, testosterone levels, and menstrual cycle regularity.
A 2010 meta-analysis (Journal of Obstetrics and Gynaecology Canada, Salehpour et al.) found NAC produced significant improvements in ovulation and pregnancy rates vs. placebo in PCOS women.
Combined with clomiphene: Multiple RCTs have found NAC as an adjunct to clomiphene citrate (an ovulation inducer) improves ovulation and pregnancy rates compared to clomiphene alone.
Comparison with metformin: A 2007 RCT found NAC (1.8g/day) and metformin (500mg three times daily) produced similar improvements in menstrual regularity, testosterone, and fasting glucose over 24 weeks — with NAC better tolerated (fewer GI side effects).
Typical dose: 600–1,800mg/day, often divided into two to three doses
Combining These Supplements
| Goal | Primary Evidence Supplement | Notes |
|---|---|---|
| Improve insulin sensitivity | Berberine or inositol | Both have strong evidence; berberine may be stronger metabolically |
| Restore ovulation and menstrual regularity | Myo-inositol (40:1 MI:DCI ratio) | Most specific evidence for ovulatory function |
| Reduce androgen effects | Spearmint tea + inositol + NAC | Spearmint has limited evidence for anti-androgenic effects; others via insulin pathway |
| Reduce oxidative stress | NAC | Primary mechanism for this outcome |
| Comprehensive metabolic support | Inositol + berberine (lower dose) | Can combine but monitor for additive hypoglycemic effects |
Inositol and berberine are sometimes combined in PCOS protocols. Both have insulin-sensitizing effects through different mechanisms. There is limited clinical data on the combination specifically, but mechanistically they are complementary. Anyone on blood sugar medications (including metformin) should be aware of additive hypoglycemic potential.
Related: Natural GLP-1 Support: What Berberine, Fiber, and Other Compounds May Do · PCOS Supplement Stack: What the Evidence Actually Supports · Vitamin D Dosage Calculator
Be the first to try Prova
We're building an app to track whether women's health and hormonal support actually works. Join the waitlist.